Inside an unassuming building in Winnipeg's core, a small team is working to protect people from dangerous street drugs. Main Street Project's safe supply program provides those addicted primarily to ...

President Trump warned Iran that he is considering next steps with the country if they do not end their nuclear program. 'Everyone here is irate': White House scrambles after tariff loss as Trump ...

Yo-Chi has rolled out a “Walk Don’t Run Club” discount on Sundays before 2pm – where punters can receive a discount on their frozen yoghurt bowls in exchange for completing a certain step count that ...

The director of the National Institutes of Health, Dr. Jay Bhattacharya, will also take on the temporary role of acting director of the US Centers for Disease Control and Prevention, an administration ...

The NEXT Steps Coaching Program moves women from confusion to clarity, from “I don’t even know what I want anymore” to “I have a clear vision and a plan, and I’m actually living it.” “I watched ...

The Reclamation Life Coach, formally introduces the NEXT Steps Coaching Program, a thorough coaching method meant to assist women in transition to remember their dreams, rediscover their passion, and ...

The State Board of Education honored five Alabama schools that were National Blue Ribbon nominees, despite the U.S. Department of Education ending the long running program in August 2025. On Thursday, ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

LOUISVILLE, Ky. — Five days a week, Whitney Stevens walks into the same rehab room at UofL Health’s Frazier Rehab Institute. Inside, music fills the space. Physical therapists sing. Instruments shake.

In an effort to strengthen its forces in 2024, the U.S. Air Force began a new warrant officer program for airmen to become experts on capabilities and deliver critical effects through technology. The ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.